133 related articles for article (PubMed ID: 6356460)
1. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
[No Abstract] [Full Text] [Related]
2. [Effect of heparin and prostacyclin on blood platelet activity].
Kisiel S; Myśliwiec M; Jakubowska I; Rydzewski A
Pol Tyg Lek; 1983 Jun; 38(24):717-20. PubMed ID: 6359097
[No Abstract] [Full Text] [Related]
3. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
Yardumian DA; O'Flynn K; Linch DC; Machin SJ
Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647
[TBL] [Abstract][Full Text] [Related]
4. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets.
Mastacchi R; Barbanti M; Bianchini P; Osima B
Agents Actions; 1986 Mar; 17(5-6):512-4. PubMed ID: 3518359
[TBL] [Abstract][Full Text] [Related]
5. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
6. Heparin neutralization of PGI2: effects upon platelets.
Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
[TBL] [Abstract][Full Text] [Related]
7. Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs.
Velders AJ; Wildevuur CR
Ann Thorac Surg; 1986 Aug; 42(2):168-71. PubMed ID: 3527093
[TBL] [Abstract][Full Text] [Related]
8. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
[TBL] [Abstract][Full Text] [Related]
9. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
Maurin N
Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
[TBL] [Abstract][Full Text] [Related]
10. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
Michel G; Seipp U
Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
[TBL] [Abstract][Full Text] [Related]
11. Platelet involvement in the activated coagulation time of heparinized blood.
Moorehead MT; Westengard JC; Bull BS
Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
[TBL] [Abstract][Full Text] [Related]
12. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
Pataricza J; Bor P; Szekeres L
Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
Kindness G; Williamson FB; Long WF
Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
[No Abstract] [Full Text] [Related]
15. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
Hamid S; Whittle BJ
Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
19. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.
Szczeklik A; Gryglewski RJ; Nizankowski R; Musiał J; Pietoń R; Mruk J
Pharmacol Res Commun; 1978 Jun; 10(6):545-56. PubMed ID: 358212
[No Abstract] [Full Text] [Related]
20. Platelet sensitivity to prostacyclin in diabetes mellitus.
Pillay PK; Pillay U; Balasubramaniam P; Lee KO
Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
